<DOC>
	<DOCNO>NCT00312182</DOCNO>
	<brief_summary>To assess nelfinavir clinically meaninful effect cardiac function , namely ECG evaluation</brief_summary>
	<brief_title>Thorough QT Study Nelfinavir</brief_title>
	<detailed_description />
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Healthy male female subject age 18 55 year , inclusive . Body Mass Index ( BMI ) approximately 18 30 kg/m2 . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>